Twin CHCH proteins, CHCHD2, and CHCHD10: Key molecules of parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia

39Citations
Citations of this article
95Readers
Mendeley users who have this article in their library.

Abstract

Mutations of coiled-coil-helix-coiled-coil-helix domain containing 2 (CHCHD2) and 10 (CHCHD10) have been found to be linked to Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS), and/or frontotemporal lobe dementia (FTD). CHCHD2 and CHCHD10 proteins, which are homologous proteins with 54% identity in amino acid sequence, belong to the mitochondrial coiled-coil-helix-coiled-coil-helix (CHCH) domain protein family. A series of studies reveals that these twin proteins form a multimodal complex, producing a variety of pathophysiology by the disease-causing variants of these proteins. In this review, we summarize the present knowledge about the physiological and pathological roles of twin proteins, CHCHD2 and CHCHD10, in neurodegenerative diseases.

Cite

CITATION STYLE

APA

Imai, Y., Meng, H., Shiba-Fukushima, K., & Hattori, N. (2019, February 2). Twin CHCH proteins, CHCHD2, and CHCHD10: Key molecules of parkinson’s disease, amyotrophic lateral sclerosis, and frontotemporal dementia. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms20040908

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free